Hopefully the LANI phase III trial shows an improved performance compared to Tamiflu... now wouldn't that make headlines! Gee, you would think marketing partners would be jumping over each other to get their hands on LANI.
- Forums
- ASX - By Stock
- BTA
- h1n1: peramivir only 3x less useless tha tami
h1n1: peramivir only 3x less useless tha tami, page-3
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online